• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发病共存。

Multimorbidity.

机构信息

Research Unit for Musculoskeletal Function and Physiotherapy, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.

The Research Unit PROgrez, Department of Physiotherapy and Occupational Therapy, Næstved-Slagelse-Ringsted Hospitals, Region Zealand, Slagelse, Denmark.

出版信息

Nat Rev Dis Primers. 2022 Jul 14;8(1):48. doi: 10.1038/s41572-022-00376-4.

DOI:10.1038/s41572-022-00376-4
PMID:35835758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7613517/
Abstract

Multimorbidity (two or more coexisting conditions in an individual) is a growing global challenge with substantial effects on individuals, carers and society. Multimorbidity occurs a decade earlier in socioeconomically deprived communities and is associated with premature death, poorer function and quality of life and increased health-care utilization. Mechanisms underlying the development of multimorbidity are complex, interrelated and multilevel, but are related to ageing and underlying biological mechanisms and broader determinants of health such as socioeconomic deprivation. Little is known about prevention of multimorbidity, but focusing on psychosocial and behavioural factors, particularly population level interventions and structural changes, is likely to be beneficial. Most clinical practice guidelines and health-care training and delivery focus on single diseases, leading to care that is sometimes inadequate and potentially harmful. Multimorbidity requires person-centred care, prioritizing what matters most to the individual and the individual's carers, ensuring care that is effectively coordinated and minimally disruptive, and aligns with the patient's values. Interventions are likely to be complex and multifaceted. Although an increasing number of studies have examined multimorbidity interventions, there is still limited evidence to support any approach. Greater investment in multimorbidity research and training along with reconfiguration of health care supporting the management of multimorbidity is urgently needed.

摘要

多种疾病(个体中同时存在两种或多种疾病)是一个日益严峻的全球性挑战,对个人、护理人员和社会都有重大影响。在社会经济条件较差的社区,多种疾病的发生时间提前了十年,与过早死亡、功能和生活质量较差以及医疗保健利用率增加有关。多种疾病发展的潜在机制复杂、相互关联且多层次,但与衰老和潜在的生物学机制以及健康的更广泛决定因素(如社会经济贫困)有关。关于多种疾病的预防知之甚少,但关注社会心理和行为因素,特别是针对人群的干预措施和结构性变革,可能是有益的。大多数临床实践指南以及医疗保健培训和实施都侧重于单一疾病,导致护理有时不够充分,甚至可能有害。多种疾病需要以人为本的护理,优先考虑对个人和个人护理者最重要的事项,确保护理得到有效协调且尽量减少干扰,并与患者的价值观保持一致。干预措施可能很复杂,需要多方面的措施。尽管越来越多的研究探讨了多种疾病的干预措施,但仍缺乏支持任何方法的证据。迫切需要增加对多种疾病研究和培训的投资,并对医疗保健进行重新配置,以支持多种疾病的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb9d/7613517/53e4a59d2608/EMS152972-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb9d/7613517/8acda5f591a0/EMS152972-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb9d/7613517/51bdd02c0d85/EMS152972-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb9d/7613517/7c7494004af0/EMS152972-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb9d/7613517/53e4a59d2608/EMS152972-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb9d/7613517/8acda5f591a0/EMS152972-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb9d/7613517/51bdd02c0d85/EMS152972-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb9d/7613517/7c7494004af0/EMS152972-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb9d/7613517/53e4a59d2608/EMS152972-f004.jpg

相似文献

1
Multimorbidity.多发病共存。
Nat Rev Dis Primers. 2022 Jul 14;8(1):48. doi: 10.1038/s41572-022-00376-4.
2
Planning and optimising CHAT&PLAN: A conversation-based intervention to promote person-centred care for older people living with multimorbidity.规划和优化 CHAT&PLAN:基于对话的干预措施,以促进多病共存的老年人的以患者为中心的护理。
PLoS One. 2020 Oct 16;15(10):e0240516. doi: 10.1371/journal.pone.0240516. eCollection 2020.
3
Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.针对多病共存和多种药物治疗的老年人减药:TAILOR 证据综合。
Health Technol Assess. 2022 Jul;26(32):1-148. doi: 10.3310/AAFO2475.
4
Contemporary perspectives in COPD: Patient burden, the role of gender and trajectories of multimorbidity.慢性阻塞性肺疾病的当代观点:患者负担、性别作用和多种共病轨迹。
Respirology. 2021 May;26(5):419-441. doi: 10.1111/resp.14032. Epub 2021 Mar 9.
5
Double trouble: the impact of multimorbidity and deprivation on preference-weighted health related quality of life a cross sectional analysis of the Scottish Health Survey.双重困境:多重疾病负担和贫困对偏好加权健康相关生活质量的影响——苏格兰健康调查的横断面分析。
Int J Equity Health. 2013 Aug 20;12:67. doi: 10.1186/1475-9276-12-67.
6
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.共病的流行病学及其对医疗保健、研究和医学教育的影响:一项横断面研究。
Lancet. 2012 Jul 7;380(9836):37-43. doi: 10.1016/S0140-6736(12)60240-2. Epub 2012 May 10.
7
Multimorbidity: a challenge and opportunity for the dental profession.多重疾病:牙科行业面临的挑战与机遇
Br Dent J. 2020 Sep;229(5):282-286. doi: 10.1038/s41415-020-2056-y. Epub 2020 Sep 11.
8
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
Multimorbidity and person-centred care in a socioeconomically deprived community: a qualitative study.社会经济贫困社区的多病共存和以患者为中心的护理:一项定性研究。
Br J Gen Pract. 2024 Nov 28;74(749):e805-e813. doi: 10.3399/BJGP.2024.0286. Print 2024 Dec.

引用本文的文献

1
Psychometric Validation of the Cantonese Version of the Patient-Centered Primary Care Instrument for Multimorbid Patients in Hong Kong.香港多病症患者以患者为中心的初级保健工具粤语版的心理测量学验证
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251368995. doi: 10.1177/21501319251368995. Epub 2025 Sep 16.
2
Co-creating community engagement and involvement strategies: understanding challenges and needs of people living with multiple long-term conditions and stakeholders' perspectives in India and Nepal.共同制定社区参与和融入策略:了解印度和尼泊尔患有多种慢性病的人群面临的挑战与需求以及利益相关者的观点。
BMJ Glob Health. 2025 Sep 15;10(9):e018968. doi: 10.1136/bmjgh-2025-018968.
3

本文引用的文献

1
Experiences of multimorbidity in urban and rural Malawi: An interview study of burdens of treatment and lack of treatment.马拉维城乡地区的多病共存经历:一项关于治疗负担和治疗缺失的访谈研究
PLOS Glob Public Health. 2022 Mar 24;2(3):e0000139. doi: 10.1371/journal.pgph.0000139. eCollection 2022.
2
Burden of treatment as a measure of healthcare quality: An innovative approach to addressing global inequities in multimorbidity.将治疗负担作为衡量医疗质量的指标:一种解决全球多重疾病不平等问题的创新方法。
PLOS Glob Public Health. 2022 May 10;2(5):e0000484. doi: 10.1371/journal.pgph.0000484. eCollection 2022.
3
Burden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases Study 2019.
Development and validation of nomogram for predicting cognitive frailty with multimorbidity: a cross-sectional study.
用于预测多重疾病患者认知衰弱的列线图的开发与验证:一项横断面研究
Front Public Health. 2025 Aug 29;13:1606505. doi: 10.3389/fpubh.2025.1606505. eCollection 2025.
4
Association between the English National Health Service Diabetes Prevention Programme and incident multiple long-term conditions.英国国民健康服务糖尿病预防计划与新发多种长期病症之间的关联
Nat Med. 2025 Sep 10. doi: 10.1038/s41591-025-03922-1.
5
Clinical, biographical and healthcare-related factors associated with accelerated health decline in persons with multimorbidity: an evidence mapping review protocol.与多病共存者健康加速衰退相关的临床、传记及医疗保健相关因素:一项证据图谱综述方案
BMJ Open. 2025 Sep 9;15(9):e100699. doi: 10.1136/bmjopen-2025-100699.
6
Prevalence and patterns of multimorbidity among adults in rural Shanxi Province, China: A post-hoc exploratory subgroup analysis of a cross-sectional study.中国山西省农村成年人中多重疾病的患病率及模式:一项横断面研究的事后探索性亚组分析
PLoS One. 2025 Sep 10;20(9):e0330935. doi: 10.1371/journal.pone.0330935. eCollection 2025.
7
Prevalence and patterns of multimorbidity among mining workers of Odisha, India: a cross-sectional study.印度奥里萨邦矿工中多病共存的患病率及模式:一项横断面研究
Front Public Health. 2025 Aug 19;13:1613856. doi: 10.3389/fpubh.2025.1613856. eCollection 2025.
8
Clinically validated graphical approaches identify hepatosplenic multimorbidity in individuals at risk of schistosomiasis.经临床验证的图形化方法可识别血吸虫病高危个体的肝脾合并症。
R Soc Open Sci. 2025 Jul 16;12(7):242256. doi: 10.1098/rsos.242256. eCollection 2025 Jul.
9
Patterns of Analgesic Prescribing and High-Risk Prescribing in Primary Care in Ireland 2014-2022-A Repeated Cross-Sectional Study.2014 - 2022年爱尔兰初级保健中镇痛药处方模式与高风险处方——一项重复横断面研究
Eur J Pain. 2025 Oct;29(9):e70115. doi: 10.1002/ejp.70115.
10
Network of doctors for multimorbidity and diabetes: Development of the NOMAD intervention - a multidisciplinary team for patients with diabetes and multimorbidity.多病共患与糖尿病医生网络:NOMAD干预措施的制定——一个针对糖尿病和多病共患患者的多学科团队。
J Multimorb Comorb. 2025 Aug 26;15:26335565251366466. doi: 10.1177/26335565251366466. eCollection 2025 Jan-Dec.
欧盟 10-24 岁青少年人群的非传染性疾病负担:2019 年全球疾病负担研究的系统分析。
Lancet Child Adolesc Health. 2022 Jun;6(6):367-383. doi: 10.1016/S2352-4642(22)00073-6. Epub 2022 Mar 24.
4
Biological mechanisms of aging predict age-related disease co-occurrence in patients.衰老的生物学机制预测了患者中与年龄相关的疾病同时发生。
Aging Cell. 2022 Apr;21(4):e13524. doi: 10.1111/acel.13524. Epub 2022 Mar 8.
5
Italian guidelines on management of persons with multimorbidity and polypharmacy.意大利关于多病共存和多重用药人群管理的指南。
Aging Clin Exp Res. 2022 May;34(5):989-996. doi: 10.1007/s40520-022-02094-z. Epub 2022 Mar 6.
6
Development of a core outcome set for multimorbidity trials in low/middle-income countries (COSMOS): study protocol.制定用于中低收入国家多病种试验的核心结局集(COSMOS):研究方案。
BMJ Open. 2022 Feb 16;12(2):e051810. doi: 10.1136/bmjopen-2021-051810.
7
Multimorbidity of non-communicable diseases in low-income and middle-income countries: a systematic review and meta-analysis.低收入和中等收入国家非传染性疾病的多种共存疾病:系统评价和荟萃分析。
BMJ Open. 2022 Jan 21;12(1):e049133. doi: 10.1136/bmjopen-2021-049133.
8
GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial.爱尔兰初级保健中多药治疗、撤药和多病共存老年人患者优先事项的全科医生提供药物治疗审查(SPPiRE 研究):一项集群随机对照试验。
PLoS Med. 2022 Jan 5;19(1):e1003862. doi: 10.1371/journal.pmed.1003862. eCollection 2022 Jan.
9
Studying trajectories of multimorbidity: a systematic scoping review of longitudinal approaches and evidence.研究多种疾病的轨迹:纵向方法和证据的系统范围综述。
BMJ Open. 2021 Nov 22;11(11):e048485. doi: 10.1136/bmjopen-2020-048485.
10
Population attributable risk for multimorbidity among adult women in India: Do smoking tobacco, chewing tobacco and consuming alcohol make a difference?印度成年女性多种疾病的人群归因风险:吸烟、嚼烟和饮酒有区别吗?
PLoS One. 2021 Nov 3;16(11):e0259578. doi: 10.1371/journal.pone.0259578. eCollection 2021.